Trial Profile
Correction of Hemoglobin and Outcomes In Renal Insufficiency
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms CHOIR
- Sponsors Janssen Research & Development
- 12 Feb 2016 New trial record